On June 29, the Food and Drug Administration (FDA) approved Phesgo, a breast cancer treatment that health professionals can administer at home. Phesgo is a fixed-dose combination of two monoclonal antibodies and enables the treatment of early and metastatic HER2 positive breast cancer for outpatients. The two monoclonal antibodies are …
Read More »
Text size Dirk Waem / Getty Images NASH was once the next big thing for big drug companies; a newly defined disorder that requires chronic treatment that affects millions of people in developed countries. Dozens of companies are developing drugs for the disease, which can cause life-threatening conditions like decompensated …
Read More »
A look at the number of state hospital beds in use by patients with COVID-19 (in red), patients without COVID (purple), and the rate of bed availability across the pandemic as more were installed (blue). Jerry Nowicki / Capitol News Illinois The number of confirmed cases of COVID-19 in Champaign …
Read More »
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured and responsible approach to the price of treatments and vaccines during the pandemic. Gilead GILD Shares, It gained 0.9% in trading on Monday following …
Read More »
European stocks struggled for direction when a new week began on Monday, and investor focus remained on rising US coronavirus infection rates. Yielding past gains, the Stoxx Europe 600 SXXP Index, -0.01% it held steady at 358.09, after a 1.9% drop last week. The German DAX + 0.40% rose 0.2%, …
Read More »